Cutting-edge technologies revealed, from CCTV AI analysis to quantum and new drugs
Big Wave Death Valley Investment Cold Wave Overcoming Sustainable Growth Support
A venue has been created for 10 companies, including 5 deep tech companies and 5 biotech companies, to introduce and promote their competitive edge and innovative technologies so that they can continue to grow sustainably during the cold investment season.
Incheon Metropolitan City and Incheon Creative Economy Innovation Center (CEO Lee Han-seop) held a joint investment attraction platform, BiiG Wave, in Seoul on the 16th to present investment attraction business plans for startups selected for support this year.
This year, a total of 306 companies applied for Big Wave, confirming the high level of interest with a competition rate of over 30.1, the highest ever.
The 10 companies that were finally selected through fierce competition consist of 5 ‘deep tech’ companies and 5 ‘biohealth’ companies with high future growth potential.

▲May I CEO Kim Chan-gyu is giving a presentation.
Mayi (CEO Kim Chan-gyu), who gave the presentation first, is a data analysis company that analyzes store CCTVs with artificial intelligence and helps establish store operations and marketing strategies based on visitor data.
Mayi's greatest competitive edge is that it is easy to introduce and cost-effective as it utilizes existing CCTV infrastructure without additional equipment. In particular, the company's self-developed 'multi-camera tracking technology' can analyze a single customer's movement path across multiple CCTVs with a high accuracy of 92%.

▲VIT Executive Director Kang Hyuk-jin is giving a presentation.
BTE (CEO: Gyu-Jeong Shim) is a specialized company that provides hydrogen full-cycle solutions, starting with hydrogen charging equipment and successfully commercializing fuel cell solutions.
As for core competitiveness, both the main products, fuel cell generators and chargers, are easy to move and install, and the introduction cost is dramatically lower than that of large-scale fixed facilities, which has significantly lowered the entry barrier for customers.

▲ScalaData CEO Ye-Chan Yoon is giving a presentation.
ScalaData (CEO Ye-chan Yoon) operates the electric vehicle charging infrastructure service platform ‘Everyone’s Charging.’
The biggest competitive edge is that it has secured overwhelming charging infrastructure accessibility, covering approximately 84% of rapid chargers nationwide, through partnerships with 61 charging operators, the largest number in the industry.

> ▲Speed Floor CEO Hong Seok-min is giving a presentation.
Speedfloor (Hong Seok-min, Hong Hyun-jin, co-CEOs) is a logistics loading and unloading automation company. Its greatest competitive edge is its unique connection technology that solves the final disconnection section of logistics automation, ‘loading and unloading,’ and it has the versatility to be applied to all types of vehicles, from 1-ton parcels to large containers.

▲GQT Korea CEO Kwak Seung-hwan is giving a presentation.
GQT Korea (CEO Kwak Seung-hwan) is a quantum communication and quantum center specialized company. It has key members who worked together with SK Telecom for 15 years to successfully build the world's first nationwide quantum cryptography network and commercialize the quantum random number generator for Samsung Galaxy quantum phone. In addition, it has internalized all technologies from the design of the core component, the 'chip', to the development of the final 'application system'.

▲DeepCardio CEO Wonik Choi is giving a presentation.
Deep Cardio (CEO Daehyuk Kim and Wonik Choi) is a company specializing in AI-based heart disease diagnosis services. It is the first in the world to develop and commercialize a technology that ‘predicts the risk of paroxysmal atrial fibrillation from normal electrocardiograms,’ which even doctors were unable to diagnose. This technology has been verified for both its technical excellence and effectiveness through numerous SCIE-level papers published, joint research with top domestic and international hospitals such as Seoul National University and Severance Hospital, and approval from the Ministry of Food and Drug Safety.

▲Bathflex CEO Kang Cheok-gu is giving a presentation.
Bathflex (CEO Kang Cheok-gu) is a CDMO (contract development and manufacturing organization) specializing in catheters (medical tubes) and convergent medical devices.
We have a rare high value-added 'medical precision tube extrusion technology' in Korea. Thanks to this technology, we can go beyond simple consignment production and conduct joint development with our clients from the design stage.
.jpg)
▲Billix CEO Kim Myeong-lip is giving a presentation.
Billix (CEO Myung-lip Kim) has converted bilirubin, a powerful antioxidant in the human body but difficult to use as a medicine, into a stable nanoparticle drug, Brixelle®, through its own synthetic and PEGylation technologies. Brickel is highly soluble in water, remains in the body for more than 80 hours, and has the property of targeting and finding areas of inflammation.

▲Appfinder Therapeutics CEO Han Seong-gu is giving a presentation.
AppFinder Therapeutics (CEO Seong-gu Han) is offering its representative solutions including the 'PepFc® platform' that replaces the FC region of large antibodies with small peptides to miniaturize antibodies while extending their efficacy duration, and the 'AbFinder® platform' that efficiently discovers and develops new antibodies.
In terms of competitiveness, the 'PepFcⓡ platform' is the only technology that can simultaneously solve the chronic problems of existing antibody drugs: tissue penetration, half-life, and non-target toxicity.
.jpg)
▲MXBio CEO Jaehyun Lee is giving a presentation.
MXBio (CEO Jae-Hyeon Lee) has developed 'Perimedi', an ointment that treats peri-implantitis, a condition for which there was no existing treatment, using a non-surgical method.
In a phase 3 clinical trial targeting patients with severe peri-implantitis, it statistically demonstrated superior efficacy compared to existing treatments, securing strong medical evidence.
Meanwhile, Big Wave, which is now in its fifth year, cooperates with investors from the stage of selecting support targets, and after selection, it conducts global We focused on achieving tangible results in attracting investment, such as strengthening ties with investors.
In addition, we are expanding support to help promising startups overcome the investment cold wave called Death Valley and continue to grow sustainably.
Lee Han-seop, CEO of Incheon Center, said, “Big Wave has established itself as a key platform for discovering and driving growth of innovative technology startups in Korea over the past five years,” and added, “We will fully utilize the center’s capabilities and network to support the selected companies so that they can grow into unicorns.”